For citations:
Komarov T.N., Karnakova K.K., Bagaeva N.S., Archakova O.A., Popova M.O., Shcherbakova V.S., Zaslavskaya K.Ya., Bely P.A., Shohin I.E. Reciprocal Impact of Molnupiravir and Favipiravir Monocomponents of the Combination Drug on Each Other's Pharmacokinetics in a Phase I Clinical Trial. Drug development & registration. 2024;13(1):272-280. https://doi.org/10.33380/2305-2066-2024-13-1-1761
Views PDF (Eng): 19
Email this article 